Semaglutide Compare Semaglutide Compare
Semaglutide Compare

Is semaglutide available on the NHS?

Last reviewed: 2026-05-23 Checked against: current public provider and brand pages

Yes, semaglutide is available on the NHS, but the NHS route depends on what it is being prescribed for and which brand is involved. That is why it helps to keep Wegovy, Ozempic and Rybelsus separate before comparing private provider pages.

NHS position

Semaglutide exists on the NHS for obesity and type 2 diabetes, but not as one single route

The NHS describes semaglutide as a medicine used to treat obesity under the brand name Wegovy and to manage type 2 diabetes under the brand names Ozempic and Rybelsus. That means the NHS route changes depending on the brand, the reason for treatment and the pathway you are in.

Source: NHS semaglutide guidance.

How the routes differ

The NHS questions change with the brand

Brand or route How the NHS frames it What that means for comparison
Wegovy Obesity treatment route Usually part of a weight-management pathway rather than a simple retail-style comparison.
Ozempic Type 2 diabetes route High public awareness, but not the same thing as the main UK private weight-management lane.
Rybelsus Type 2 diabetes tablet route Important for oral semaglutide context, but not a like-for-like substitute for weekly Wegovy pages.
Private pages

Why NHS access and private provider comparison should be kept separate

NHS access is shaped by eligibility criteria, referral routes and clinical pathways. Private provider comparison is usually about provider checks, route wording, delivery, support and visible cost. They are related, but they are not interchangeable.

Wegovy

Use the treatment page when the question is really about semaglutide for weight management.